Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.

Abstract

There remains a high unmet medical need for a safe oral therapy for thrombotic disorders. The serine protease factor Xa (fXa), with its central role in the coagulation cascade, is among the more promising targets for anticoagulant therapy and has been the subject of intensive drug discovery efforts. Investigation of a hit from high-throughput screening… (More)

Topics

  • Presentations referencing similar topics